Skip to main content

MoneyWorks4Me

Ipca Laboratories - Quaterly Results

06 Nov 2026 Evaluate
The Revenue for the quarter ended  September 2026 of Rs. 22556.10 millions grew by 16.85 % from Rs. 19303.20 millions.A comparatively good net profit growth of 27.09% to Rs. 3872.90 millions was reported for the quarter ended September 2026 compared to Rs. 3047.40 millions of previous same quarter.Operating Profit saw a handsome growth to 6159.80 millions from 4866.30 millions in the quarter ended September 2026.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 22556.10 19303.20 16.85 43748.50 36772.20 18.97 73367.50 66779.20 9.87
Other Income 189.20 219.20 -13.69 363.40 469.40 -22.58 946.40 712.90 32.75
PBIDT 6159.80 4866.30 26.58 12110.40 9185.70 31.84 18749.30 15963.20 17.45
Interest 46.80 114.60 -59.16 97.20 235.20 -58.67 435.10 630.40 -30.98
PBDT 6113.00 4751.70 28.65 12013.20 8950.50 34.22 18010.00 12517.40 43.88
Depreciation 775.90 668.60 16.05 1522.00 1299.90 17.09 2688.70 2519.70 6.71
PBT 5337.10 4083.10 30.71 10491.20 7650.60 37.13 15321.30 9997.70 53.25
TAX 1464.20 1035.70 41.37 2885.40 1982.80 45.52 3996.10 3490.10 14.50
Deferred Tax 50.00 -9.50 -626.32 170.00 11.00 1445.45 -25.10 81.10 -130.95
PAT 3872.90 3047.40 27.09 7605.80 5667.80 34.19 11325.20 6507.60 74.03
Equity 253.70 253.70 0.00 253.70 253.70 0.00 253.70 253.70 0.00
PBIDTM(%) 27.31 25.21 8.33 27.68 24.98 10.82 25.56 23.90 6.91
Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1371.20
Cipla 1409.00
Lupin 1990.00
Zydus Lifesciences 1195.00
View more..